These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Chromosomal damage in lymphocytes and fibroblasts of patients treated for testicular cancer. DeLozier-Blanchet CD Hum Genet; 1990 Oct; 85(6):675-6. PubMed ID: 2172154 [No Abstract] [Full Text] [Related]
14. Editorial Comment from Dr Beyer to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. Beyer J Int J Urol; 2015 Oct; 22(10):929-30. PubMed ID: 26105542 [No Abstract] [Full Text] [Related]
15. Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. Nakamura T Int J Urol; 2015 Oct; 22(10):928. PubMed ID: 26153458 [No Abstract] [Full Text] [Related]
16. The Danish testicular carcinoma study (DATECA). The DATECA Working Group. Dan Med Bull; 1983 Feb; 30(1):1-3. PubMed ID: 6299653 [No Abstract] [Full Text] [Related]
17. [Testicular cancer: should the contralateral testis be assessed?]. Weissbach L Urologe A; 1992 Jul; 31(4):197-8. PubMed ID: 1325081 [No Abstract] [Full Text] [Related]
18. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases]. Berger N; Droz JP Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737 [No Abstract] [Full Text] [Related]
19. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin. Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048 [No Abstract] [Full Text] [Related]
20. [Malignant testicular tumors]. Seljelid R; Miller A; Host H Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1945-8. PubMed ID: 4358494 [No Abstract] [Full Text] [Related] [Next] [New Search]